| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H6O6 |
| Molecular Weight | 174.1082 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(OC(=O)C(=O)C1=O)[C@@H](O)CO
InChI
InChIKey=SBJKKFFYIZUCET-JLAZNSOCSA-N
InChI=1S/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8H,1H2/t2-,5+/m0/s1
| Molecular Formula | C6H6O6 |
| Molecular Weight | 174.1082 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Dehydroascorbic acid (DHA) is an oxidized form of ascorbic acid. Ascorbic acid is transported in its oxidized form via GLUT1 across the blood-brain barrier. Dehydroascorbic acid delay low-density lipoprotein (LDL) oxidation when added before the initiation of the process, they accelerate the process if added to minimally oxidized LDL. Dehydroascorbic acid is used as biochemical markers of oxidative stress in clinical investigations. Dehydroascorbic acid has been used as a vitamin C dietary supplement.
CNS Activity
Originator
Approval Year
Sourcing
PubMed
Patents
Sample Use Guides
1 mM (174 mg) at 9:00 a.m. with 200 ml of mineral water.
Route of Administration:
Oral
A group of confluent monolayers of HEp-2 cells were infected with HSV-1 at a MOI of 10 and were incubated in MEM containing 0.1% BSA. At various times after the infection, dehydroascorbic acid was added to the culture medium at the final concentration of 10 mM and then the infected cells were further incubated in the presence of the reagent. The amounts of progeny virus were markedly suppressed even when the infected cells received the reagent at 11 h p.i.